Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Long-Term Debt Repayments (2016 - 2018)

Historic Long-Term Debt Repayments for Avadel Pharmaceuticals (AVDL) over the last 8 years, with Q3 2018 value amounting to $430000.0.

  • Avadel Pharmaceuticals' Long-Term Debt Repayments changed N/A to $430000.0 in Q3 2018 from the same period last year, while for Sep 2019 it was $430000.0, marking a year-over-year decrease of 9305.33%. This contributed to the annual value of $161000.0 for FY2014, which is 10909.09% up from last year.
  • Latest data reveals that Avadel Pharmaceuticals reported Long-Term Debt Repayments of $430000.0 as of Q3 2018.
  • Avadel Pharmaceuticals' 5-year Long-Term Debt Repayments high stood at $34.4 million for Q3 2014, and its period low was -$34.4 million during Q2 2014.
  • Moreover, its 4-year median value for Long-Term Debt Repayments was $61000.0 (2016), whereas its average is $50909.1.
  • Over the last 5 years, Avadel Pharmaceuticals' Long-Term Debt Repayments had its largest YoY gain of 17214500.0% in 2014, and its largest YoY loss of 18118947.37% in 2014.
  • Quarter analysis of 4 years shows Avadel Pharmaceuticals' Long-Term Debt Repayments stood at $223000.0 in 2014, then plummeted by 2695.52% to -$5.8 million in 2015, then skyrocketed by 101.05% to $61000.0 in 2016, then skyrocketed by 604.92% to $430000.0 in 2018.
  • Its Long-Term Debt Repayments stands at $430000.0 for Q3 2018, versus $369000.0 for Q2 2018 and $5.4 million for Q1 2018.